It was mixed with a ChAd63 vector encoding the liver-stage malaria antigen ME-TRAP (ChAd63-ME TRAP), and antigen chosen because, when delivered by ChAd63 as part of prime boost regimen, ME-TRAM induces modest protection against malaria in field trials20. The gene discussed is TICAM2; the disease is malaria.